EPRX
USDEupraxia Pharmaceuticals Inc. Common Stock
$5.450-0.670 (-10.948%)
Real-time Price
Healthcare
Biotechnology
Canada
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$6.120
High
$6.120
Low
$5.350
Volume
0.48M
Company Fundamentals
Market Cap
275.7M
Industry
Biotechnology
Country
Canada
Trading Stats
Avg Volume
0.09M
Exchange
NCM
Currency
USD
52-Week Range
Low $2.68Current $5.450High $7.19
Related News
GlobeNewswire
Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results
Durable symptom and tissue responses observed out to 52 weeks following a single treatment with EP-104GI Enrollment continues in Phase 2b portion of the RESOLVE Trial, with topline data expected by Q3 2026 Completed
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.